Profile and Core Competence:

NBI is a privately held research and development company with an array of nanoparticle-based  products that encompass biocompatible nanoparticles, nanoparticulate antimicrobial agents, and specialty biochemicals. Its corporate objectives are to develop new and innovative nanoparticle-based technologies and products for medical, health, hygiene and  allied industries,  and researchers. NBI is actively pursuing marketing of its products   either directly or through licensing agreements with corporate partnerships.

NBI’s core competencies include its ability to perform cutting edge original research and develop innovative pathways for the synthesis of a wide spectrum of gold, silver, palladium, iron oxide, and platinum nanoparticles, nanoconstructs and nanobioconjugates. Our proprietary technologies have allowed the  development of gold, silver, palladium and platinum nanoparticles functionalized with an array of chemical and biochemical matrices. Gum Arabic coated gold and silver nanoparticles allow systematic variations in metal content, thus providing unprecedented means of developing mono- and multi-nanolayers with assorted metal content for a variety of materials and biomedical research applications.